or Try an Advanced Search...

    Progressive Stocks List

    Symbol Grade Name % Change
    IGT F International Game Technology 0.10
    GLTO F Galecto, Inc. 5.43
    MIRM D Mirum Pharmaceuticals, Inc. -0.47
    LRMR D Larimar Therapeutics, Inc. 3.54
    FULC D Fulcrum Therapeutics, Inc. 4.37
    ITT D ITT Corporation -3.71
    BIIB D Biogen Idec Inc. -1.21
    CHX B ChampionX Corporation 1.05
    EXEL B Exelixis, Inc. 0.89
    View As Page of Charts
    Related Industries: Biotechnology Diversified Industrials Drug Manufacturers - Major Gambling Oil & Gas Equipment & Services
    Related Stock Lists: Biotechnology Medicine Cancer Disability Idiopathic Pulmonary Fibrosis Pulmonary Fibrosis Pump Acid Aerospace Components Aerospace Market Alcohol Alzheimer's Disease Artificial Lift Equipment Asset Integrity Management Ataxia Autoimmune Disorders Automation Technologies Bearings Bile Acid Bingo

    Related ETFs - A few ETFs which own one or more of the above listed Progressive stocks.

    Symbol Grade Name Weight
    PBE C PowerShares Dynamic Biotech & Genome 7.83
    BIS C ProShares UltraShort Nasdaq Biotechnology 6.85
    FBT D First Trust Amex Biotech Index Fund 6.7
    PXJ B PowerShares Dynamic Oil Services 5.31
    BBP C BioShares Biotechnology Products Fund 5.28
    View all Progressive ETFs...
    Compare ETFs
    Compare FBT to BBP Compare PBE to FBT Compare PBE to PXJ

        Progressive Stocks Recent News

        Date Stock Title
        May 2 EXEL Exelixis, Inc. (NASDAQ:EXEL) Q1 2024 Earnings Call Transcript
        May 2 ITT ITT Inc. (ITT) Q1 2024 Earnings Call Transcript
        May 2 EXEL Exelixis: With Patent Litigation Decision Due Soon, There Are Options
        May 2 ITT ITT Inc. 2024 Q1 - Results - Earnings Call Presentation
        May 2 EXEL Exelixis, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
        May 2 ITT ITT Inc. (ITT) Q1 Earnings: Surpasses Revenue Estimates with Strong Growth Across Segments
        May 2 BIIB Biogen Reports Progress on Corporate Responsibility Priorities
        May 2 ITT ITT beats Q1 estimates, raises FY guidance
        May 2 ITT ITT Reports 2024 First Quarter Earnings Per Share (EPS) of $1.34, Adjusted EPS of $1.42
        May 1 MIRM Mirum Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
        May 1 GLTO Galecto Announces First Patient Dosed in an Investigator-Initiated Phase 2 Trial of GB1211 in Combination with Pembrolizumab
        May 1 ITT ITT Q1 2024 Earnings Preview
        May 1 BIIB Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
        May 1 EXEL Exelixis (EXEL) Q1 Earnings Miss, Cabometyx Sales Fall Short
        May 1 EXEL Q1 2024 Exelixis Inc Earnings Call
        May 1 EXEL Exelixis Inc (EXEL) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
        May 1 EXEL Exelixis (EXEL) Q1 2024 Earnings Call Transcript
        May 1 EXEL Exelixis, Inc. (EXEL) Q1 2024 Earnings Call Transcript
        Apr 30 EXEL Exelixis down 7% as Q1 financial results disappoint
        Apr 30 EXEL Exelixis (EXEL) Reports Q1 Earnings: What Key Metrics Have to Say
        Related Industries: Biotechnology Diversified Industrials Drug Manufacturers - Major Gambling Oil & Gas Equipment & Services
        Related Stock Lists: Biotechnology Medicine Cancer Disability Idiopathic Pulmonary Fibrosis Pulmonary Fibrosis Pump Acid Aerospace Components Aerospace Market Alcohol Alzheimer's Disease Artificial Lift Equipment Asset Integrity Management Ataxia Autoimmune Disorders Automation Technologies Bearings Bile Acid Bingo
        Progressive

        Browse All Tags